Tianshui Zhongxing Bio-technology Co.,Ltd.
Simbol: 002772.SZ
SHZ
7.08
CNYTržna cena danes
-764.5012
Razmerje P/E
44.3411
Razmerje PEG
2.78B
Kapaciteta MRK
- 0.00%
Donos DIV
Tianshui Zhongxing Bio-technology Co.,Ltd. (002772-SZ) Finančni izkazi
Bilanca stanja
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 1323.5 | 1695.7 | 1858.6 | |||||||||||||
balance-sheet.row.short-term-investments | 0 | 285 | 369.5 | 263.4 | |||||||||||||
balance-sheet.row.net-receivables | 0 | 28.3 | 80.9 | 21.6 | |||||||||||||
balance-sheet.row.inventory | 0 | 1274.6 | 1255.5 | 1173.9 | |||||||||||||
balance-sheet.row.other-current-assets | 0 | 32.8 | 4.8 | 24.4 | |||||||||||||
balance-sheet.row.total-current-assets | 0 | 2659.2 | 3036.9 | 3078.5 | |||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 2946.8 | 3074 | 3005.4 | |||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.intangible-assets | 0 | 334.4 | 342.4 | 350.6 | |||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 334.4 | 342.4 | 350.6 | |||||||||||||
balance-sheet.row.long-term-investments | 0 | 123.7 | -285.2 | -170.9 | |||||||||||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 268.3 | |||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 9.7 | 401.1 | 19.3 | |||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 3414.6 | 3532.3 | 3472.8 | |||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.total-assets | 0 | 6073.8 | 6569.1 | 6551.3 | |||||||||||||
balance-sheet.row.account-payables | 0 | 179.1 | 205.4 | 155.6 | |||||||||||||
balance-sheet.row.short-term-debt | 0 | 1009.7 | 980.4 | 422.6 | |||||||||||||
balance-sheet.row.tax-payables | 0 | 1 | 1 | 0.7 | |||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 1074.5 | 1622.5 | 2330.7 | |||||||||||||
Deferred Revenue Non Current | 0 | 102.9 | 118.5 | 127.2 | |||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||||||
balance-sheet.row.other-current-liab | 0 | 266.7 | 252.2 | 234.8 | |||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 1074.7 | 1741 | 2480.6 | |||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 0.3 | 0.3 | 0.3 | |||||||||||||
balance-sheet.row.total-liab | 0 | 2535.3 | 3184.5 | 3300.2 | |||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||
balance-sheet.row.common-stock | 0 | 393.2 | 407.5 | 407.4 | |||||||||||||
balance-sheet.row.retained-earnings | 0 | 958.9 | 931.5 | 819.4 | |||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 60 | 26.1 | 27.3 | |||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 2020.3 | 2016.6 | 1994.5 | |||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 3432.5 | 3381.6 | 3248.6 | |||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 6073.8 | 6569.1 | 6551.3 | |||||||||||||
balance-sheet.row.minority-interest | 0 | 3 | 3.1 | 2.5 | |||||||||||||
balance-sheet.row.total-equity | 0 | 3435.5 | 3384.7 | 3251.1 | |||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||||||
Total Investments | 0 | 408.7 | 84.3 | 92.5 | |||||||||||||
balance-sheet.row.total-debt | 0 | 2084.4 | 2602.9 | 2753.3 | |||||||||||||
balance-sheet.row.net-debt | 0 | 1045.9 | 1276.7 | 1158.1 |
Izkaz denarnih tokov
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 159.6 | 158.9 | 54.3 | |||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 268.9 | 275.4 | 257.5 | |||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | -10.9 | -28 | |||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 10.9 | 28 | |||||||||||||
cash-flows.row.change-in-working-capital | 0 | -11.7 | -77.9 | -788.6 | |||||||||||||
cash-flows.row.account-receivables | 0 | 20.7 | -35.7 | 2.5 | |||||||||||||
cash-flows.row.inventory | 0 | -26.3 | -85.4 | -912.1 | |||||||||||||
cash-flows.row.account-payables | 0 | -6.1 | 43.2 | 121 | |||||||||||||
cash-flows.row.other-working-capital | 0 | 0 | 0 | 0 | |||||||||||||
cash-flows.row.other-non-cash-items | 0 | 107.8 | 137.3 | 63.1 | |||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -107 | -245.9 | -286.5 | |||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 3 | 0.4 | |||||||||||||
cash-flows.row.purchases-of-investments | 0 | -400 | -1310 | -510 | |||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 450 | 1172.5 | 959.4 | |||||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | 0 | 0.7 | |||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -57 | -380.4 | 164.1 | |||||||||||||
cash-flows.row.debt-repayment | 0 | -544.4 | -1520.6 | -680.8 | |||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | |||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||||
cash-flows.row.dividends-paid | 0 | -117.9 | -170.3 | -148.7 | |||||||||||||
cash-flows.row.other-financing-activites | 0 | -92.9 | 1323 | 1459.6 | |||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -755.2 | -367.9 | 630.1 | |||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | |||||||||||||
cash-flows.row.net-change-in-cash | 0 | -287.7 | -254.6 | 380.6 | |||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 1038.5 | 1326.2 | 1580.8 | |||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 1326.2 | 1580.8 | 1200.2 | |||||||||||||
cash-flows.row.operating-cash-flow | 0 | 524.5 | 493.7 | -413.7 | |||||||||||||
cash-flows.row.capital-expenditure | 0 | -107 | -245.9 | -286.5 | |||||||||||||
cash-flows.row.free-cash-flow | 0 | 417.5 | 247.8 | -700.2 |
Vrstica izkaza poslovnega izida
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 1928.1 | 1970.3 | 1556.1 | |||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 1500.6 | 1468.8 | 1268.2 | |||||||||||||
income-statement-row.row.gross-profit | 0 | 427.5 | 501.5 | 288 | |||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||
income-statement-row.row.other-expenses | 0 | 0.6 | 33.7 | 4.5 | |||||||||||||
income-statement-row.row.operating-expenses | 0 | 247.2 | 231 | 187.4 | |||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 1747.7 | 1699.8 | 1455.6 | |||||||||||||
income-statement-row.row.interest-income | 0 | 31.6 | 31 | 53.6 | |||||||||||||
income-statement-row.row.interest-expense | 0 | 83.6 | 90.5 | 80.9 | |||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -17.6 | -148.7 | -67.3 | |||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 0.6 | 33.7 | 4.5 | |||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -17.6 | -148.7 | -67.3 | |||||||||||||
income-statement-row.row.interest-expense | 0 | 83.6 | 90.5 | 80.9 | |||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 268.9 | 275.4 | 257.5 | |||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||||||
income-statement-row.row.operating-income | 0 | 180.4 | 307.6 | 121.6 | |||||||||||||
income-statement-row.row.income-before-tax | 0 | 162.8 | 158.9 | 54.3 | |||||||||||||
income-statement-row.row.income-tax-expense | 0 | 3.2 | 0 | 66.7 | |||||||||||||
income-statement-row.row.net-income | 0 | 159.6 | 158.4 | -12.4 |
Pogosto zastavljeno vprašanje
Kaj je Tianshui Zhongxing Bio-technology Co.,Ltd. (002772.SZ) skupna sredstva?
Tianshui Zhongxing Bio-technology Co.,Ltd. (002772.SZ) skupna sredstva so 6073765300.000.
Kakšen je letni prihodek podjetja?
Letni prihodki so N/A.
Kolikšna je stopnja dobička podjetja?
Dobiček podjetja je 0.149.
Kakšen je prosti denarni tok podjetja?
Prosti denarni tok je 0.517.
Kolikšna je neto stopnja dobička podjetja?
Čista stopnja dobička je -0.002.
Kolikšni so skupni prihodki podjetja?
Celotni prihodki so 0.001.
Kaj je Tianshui Zhongxing Bio-technology Co.,Ltd. (002772.SZ) čisti dobiček (čisti dobiček)?
Čisti dobiček (čisti prihodek) je 159581340.000.
Kolikšen je skupni dolg podjetja?
Skupni dolg je 2084417918.000.
Kolikšni so stroški poslovanja?
Stroški poslovanja so 247154405.000.
Kolikšno je število denarnih sredstev podjetja?
Denarna sredstva podjetja so 0.000.